Journals / Turkish Journal of Gastroenterology / 2010 / Cilt: 21 - Sayı: 3

Progresif sistemik sklerozlu olgularda squamokolumnar bileşkede intestinal metaplazi sıklığı farklı mı?

Is the prevalence of intestinal metaplasia at the squamocolumnar junction different in patients with progressive sytemic sclerosis?

Pages
251–256
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, there was no difference in the prevalence of intestinal metaplasia at squamocolumnar junction between groups, and it can be pointed out that intestinal metaplasia at squamocolumnar junction might not be related with gastroesophageal reflux disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aims: Gastroesophageal reflux disease is seen frequently in patients with progressive systemic sclerosis.
📊
Key Findings & Data:Methods: Thirty-one patients with progressive systemic sclerosis (Group A), 58 patients with gastroesophageal reflux disease -without progressive systemic sclerosis (Group B) and 36 patients without progressive systemic sclerosis or gastroesophageal reflux disease (Group C) were prospectively enrolled into this study.
💡
Conclusion & Impact:However, there was no difference in the prevalence of intestinal metaplasia at squamocolumnar junction between groups, and it can be pointed out that intestinal metaplasia at squamocolumnar junction might not be related with gastroesophageal reflux disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Kadın · Orta yaşlı · İleriye dönük çalışma

Abstract

Background/aims: Gastroesophageal reflux disease is seen frequently in patients with progressive systemic sclerosis. The aim of the present study was to determine the prevalence of intestinal metaplasia-squamocolumnar junction in patients with progressive systemic sclerosis and to investigate the association with gastroesophageal reflux disease. Methods: Thirty-one patients with progressive systemic sclerosis (Group A), 58 patients with gastroesophageal reflux disease -without progressive systemic sclerosis (Group B) and 36 patients without progressive systemic sclerosis or gastroesophageal reflux disease (Group C) were prospectively enrolled into this study. Biopsies were taken from the antrum, body, squamocolumnar junction (Z-line), and from the esophagus (3 cm above the Z-line). All biopsies were independently evaluated by two pathologists who were unaware of the diagnosis. Results: We found that grade C-D esophagitis, esophageal stricture and Barrett's esophagus were statistically significantly higher in Group A (p<0.05). Intestinal metaplasia at squamocolumnar junction was detected in 31% of Group A, in 32% of Group B and in 29% of Group C patients (p>0.05), and prevalence of Helicobacter pylori was 61%, 67% and 38% in Groups A, B and C, respectively. Prevalence of Helicobacter pylori was similar in Group B and Group A, and significantly higher in Group B than Group C. Within each group, no significant relationship was detected between intestinal metaplasia at squamocolumnar junction and gender, age, smoking, alcohol consumption, body mass index, gastric atrophy, and prevalence of Helicobacter pylori. Conclusions: Patients with progressive systemic sclerosis have a higher tendency to the more severe forms and complications of gastroesophageal reflux disease including Barrett's esophagus than in those without progressive systemic sclerosis. However, there was no difference in the prevalence of intestinal metaplasia at squamocolumnar junction between groups, and it can be pointed out that intestinal metaplasia at squamocolumnar junction might not be related with gastroesophageal reflux disease.

Özet

Amaç: Gastroözofageal reflü hastalığı progresif sistemik sklerozlu olgularda sıktır. Çalıflmanın amacı, progresif sistemik sklerozlu olgulardaki squamokolumnar bileşkede intestinal metaplazi sıklığını tanımlamak ve bunun gastroözofageal reflü hastalığı ile ilişkisini araştırmaktır. Yöntem: Progresif sistemik skleroz tanısı alan 31 olgu (grup A), progresif sistemik sklerozu olmayangastroözofageal reflü hastalığı olan 58 olgu (grup B) ile progresif sistemik sklerozu ve gastroözofageal reflü hastalığı olmayan 36 olgu (grup C) prospektif olarak araştırıldı. Antrum, korpus, squamokolumnar bileşke (Z-çizgisi) ve özofagustan (Z-çizgisi 3 cm proksimalinden) alınan biyopsiler tanı bilinmeden, bağımsız 2 ayrı patolog tarafından değerlendirildi. Bulgular: Grup A'da grade C-D özofajit, özofageal sitriktür ve Barrett özofagusu anlamlı daha sık olarak saptandı (p 0.05). Helikobakter pilori sıklığı grup A'da %61 (19/31, grup B'de %67 (39/58), grup C %38 (14/36) idi. Grup B'de Helikobakter pilori sıklığı grup A ile benzerdi ve grup B'de anlamlı olacak şekilde grup C'den yüksekti. Gruplar arasında, squamokolumnar bileşkede intestinal metaplazi ve cinsiyet, yaş, sigara içme, alkol kullanımı, vücud-kitle indeksi, gastrik atrofi ve Helikobakter pilori prevalansı arasında anlamlı ilişki saptanmadı. Sonuç: Progresif sistemik sklerozlu olgularda Barrett özofagusu da dahil gastroözofageal reflü hastalığının komplikasyonları progresif sistemik sklerozlu olmayanlara gore daha sık ve daha şiddetli seyretmektedir. Bununla birlikte squamokolumnar bileşkede intestinal metaplazi sıklığı açısından gruplar arasında fark saptanmamıştır ve squamokolumnar bileşkede intestinal metaplazi ile gastroözofageal reflü hastalığı arasında ilişki olmayabileceği belirtilebilir.

🔖

Cite This Article

VARDAR, R., VARDAR, E., BOR, S. (2010). Progresif sistemik sklerozlu olgularda squamokolumnar bileşkede intestinal metaplazi sıklığı farklı mı?. Turkish Journal of Gastroenterology, Cilt: 21 - Sayı: 3, 251–256. https://ajindex.com/articles/410349

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Ntoumazios SK, Voulgari PV, Potsis K, et al. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem. Semin Arthritis Rheum 2006; 36: 173-81
  2. Yarze JC, Varg J, Stampfl D, et al. Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients. Am J Gastroenterol 1993; 88: 870-6
  3. Ebert EC. Esophageal disease in scleroderma. J Clin Gastroenterol 2006; 40: 769-75
  4. Bassotti G, Battaglia E, Debernardi V, et al. Esophageal dysfunction in scleroderma: relationship with disease subsets. Arthritis Rheum 1997; 40: 2252-9
  5. Weston S, Thumshirn M, Wiste J, Camilleri M. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol 1998; 93: 1085-9
  6. Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994; 344: 1533-6
  7. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287
  8. Hansson L, Sparen P, Nyren O. Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. Br J Surg 1993; 80: 374
  9. Bor S, Vardar R, Ormeci N, et al. Prevalence patterns of gastric cancers in Turkey: model of a developing country with high occurrence of Helicobacter pylori. J Gastroenterol Hepatol 2007; 22: 2242-5
  10. Bor S, Mandiracioglu A, Kitapcioglu G, et al. Gastroesophageal reflux disease in a low-income region in Turkey. Am J Gastroenterol 2005; 100: 759-65
  11. Bor S, Vardar R, Vardar E, et al. Endoscopic findings of gastroesophageal reflux disease in Turkey: Multicenter Prospective Study (GÖRHEN). Gastroenterology 2008; 134 (Suppl): T2014 (600)
  12. Vardar E, Vardar R, Alkanat M, et al. Intestinal metaplasia at squamocolumnar junction in a high Helicobacter pylori prevalence area. Endoscopy 2002; 34 (Suppl): 286
  13. Kitapcioglu G, Mandiracioglu A, Bor S. The validity and reliability of a gastroesophageal reflux disease questionnaire culturally-adjusted for Turkey. Dis Esophagus 2004; 17: 228-34
  14. Özayd�n N, Çal� fi, Türky�lmaz AS, Hanc�o¤lu A. Turkey Helicobacter Pylori (TURHEP) Prevalence Survey 2003, İstanbul
  15. Bor S, Mandiracoglu A, Kitapcioglu G, et al. A model for gastroesophageal reflux disease (GERD) in a developing nation (Turkey) with high H. pylori prevalence. Gut 2001; 49 (Suppl): A. 3100
  16. Stentoft P, Hendel L, Aggestrup S. Esophageal manometry a